Find an expert

Dr Cassandra Pattinson research centres around exploring the effects of sleep and circadian rhythms on health, wellbeing, and recovery across the lifespan. Dr Pattinson is a Senior Research Fellow at the Child Health Research Centre (CHRC) and the ARC centre of Excellence for the Digital Child. The Digital Child aims to support children growing up in the rapidly changing digital world, and provide strong evidence and guidance for children, families, educators, government and other concerned with children’s wellbeing. Her work has been supported by the ARC (including recently awarded an ARC Discovery Early Career Award, 2025), NHMRC, NIH and the DSTG, as well as the Australian Federal Government and Queensland Government.

Her research has involved a range of populations from children and adolescents, through to military personnel and athletes. Dr Pattinson's research spans a range of study designs and methodologies, including longitudinal studies tracking large child cohorts (>2000 children), standard observation techniques, survey and individualised standard child assessment, as well as studies employing physiological (actigraphy, spectrometry) and biological (hormones, proteomic, genomic) designs. Dr Pattinson also has a strong track record in research translation, these have included manuscripts in top scientific journals, reports for government and non-government organisations, development of professional development programs, as well as designing and presenting vodcasts and resources (e.g. fact sheets, workshops) to parent groups, young adults, government departments and the early childhood sector.

At CHRC Dr Pattinson is a part of the Community Sleep Health Group. This group collaborates with many other groups around broader issues of sleep and technology, sleep and the environment (including disasters), mental health and wellbeing, pain, disability, and new technologies and approaches.

• Deputy Director & Nuclear Medicine Specialist, Department of Nuclear Medicine & Specialised PET Services, Royal Brisbane & Women’s Hospital
• Theranostics Lead, Department of Nuclear Medicine & Specialised PET Services, Royal Brisbane & Women's Hospital
• Co-Director of Training, Department of Nuclear Medicine & Specialised PET Services, Royal Brisbane & Women’s Hospital
• Associate Professor, School of Medicine, University of Queensland

David underwent dual specialty training in both Endocrinology and Nuclear Medicine at Royal Melbourne Hospital, Austin Hospital and Peter MacCallum Cancer Centre in Melbourne. He was appointed a staff specialist at Peter MacCallum Cancer Centre at the completion of his training, where he continued to gain experience in a quaternary referral centre for theranostics treating patients from across south-east Australia and New Zealand. In 2016 he moved to Royal Brisbane & Women’s Hospital where he is currently the Deputy Director of Department of Nuclear Medicine & Specialised PET Services and nuclear medicine lead for the RBWH radionuclide therapy service.

Julie’s research is mainly focussed on gas-water-rock core reactivity at reservoir conditions using experimental, field, and geochemical modelling techniques. Recent projects have been in the application of carbon dioxide geological storage in which CO2 is captured and stored in formations generally contained by low permeability cap-rock. The safe containment of the injected CO2 and the potential changes to rock porosity, permeability, and water quality should be determined. Recent and current projects with a focus on a demonstration site in the Surat Basin (Precipice Sandstone) include the impacts of impurity or acid gases present in industrial CO2 streams (collaboration with D. Kirste, SFU), inducing carbonate precipitation (in collaboration with S. Golding), and understanding dissolved metal sources and fate. Julie has also worked closely with the CO2CRC, CTSCo, Glencore, SEAL, the NSW government, CI-NSW, and ANLEC R&D, and provided expert opinion to the Queensland Government, and input to Environmental Impacts Assessments.

Julie is currently working with landholders, the QLD regional government, RDMW, councils and industry to understand the sources of methane in aquifers of the Great Artesian Basin, especailly those overlying coal seam gas reservoirs (CSG) (with Arrow Energy, SANTOS, APLNG, H. Hoffman, K, Baublys).

Other projects include gas-water-rock or acid-rock reactivity that modify nano-porosity and gas flow in gas or oil bearing shales.

Julie Pearce graduated with an MCHEM (Hons) degree in Chemistry from the University of York, UK. She then moved to the University of Bristol to complete a Ph.D. in 2007 focusing on laser spectroscopic studies to understand the detailed reaction dynamics of atmospheric processes. From 2007 – 2009 she accepted a Japan Society for the Promotion of Science Postdoctoral Fellowship, hosted at Nagoya University, Japan. There she measured delta 13C and delta 18O isotopic signatures of CO2 simultaneously in real time in the atmosphere using a laser spectroscopic technique to understand anthropogenic and biogenic sources of CO2. After taking a career break to travel in 15 countries in Asia, she moved to Brisbane in 2010 where she is enjoying the surrounding natural beauty of Queensland.

See Google Scholar page

Research achievements other than research outputs

Dr Pedroso is an expert in numerical and computer methods for solid mechanics and materials modelling. He has a strong background in tensor calculus, partial differential equations, computational geometry, and computer programming, among other topics. Dr Pedroso has been developing methods to model the mechanical behaviour of porous media including mixtures of solids, liquids and gases. Dr Pedroso has also developed new methods in molecular dynamics to model solids and granular assemblies. Therefore, his research work is quite multi-disciplinary but revolves around computational engineering and mechanics.

Dr. Pedroso received the highly prestigious Argyris Lecture Award of 2016 from the University of Stuttgart, Germany, which is internationally recognized. The Argyris Lecture is the top award for experts working on Modeling and Simulations, in particular, with the Finite Element Method (FEM), because Prof Argyris is a pioneer of the FEM. Today, this method is the most attractive for approximating the solution of partial differential equations with complex geometries and boundary conditions. One key aspect that the committee considered in the award was the innovative papers on new techniques for porous media, such as a new method to handle unilateral and variable boundary conditions for the interface between liquid and gases within porous media.

Journal Reviews

Dr Pedroso is an expert in computational mechanics for porous media and optimisation and is reviewing papers for top journals such as Computer Methods in Applied Mechanics and Engineering, International Journal for Numerical Methods in Engineering, International Journal for Numerical and Analytical Methods in Geomechanics, Nature: Scientific Reports, Computers and Geotechnics, Geotechnique Letters, Advances in Engineering Software, Journal of Engineering Mechanics ASCE, Computer Physics Communications, International Journal of Plasticity, Soils and Foundations, Advances in Structural Engineering, Engineering Structures, among others.

Research Grants Reviewer

Dr Pedroso is an Australian Research Council (ARC) reviewer for DPs, DEs and LPs. He is also a reviewer for th Hong Kong Research Grants Council HK-RGC

Conference Services

Dr Pedroso has organised the 1st Workshop on New Advances on Computational Geomechanics in Australia in 2008 and the 5th Workshop on New Frontiers in Computational Geotechnics in 2010. Both in Brisbane, Australia.

My career has encompassed practicing, studying, and teaching design across a range of contexts. I have investigated and applied design engineering, strategic design innovation, and user centred design in maxillofacial, orthopaedic, and cardiovascular fields.

In particular, I have liaised with surgeons, prosthetists, and engineers to develop designs for patient-specific guides and implants in cranio-maxillofacial surgery; and have led the development of publications describing such innovations in peer-reviewed journals. I worked part-time on a Ph.D. to refine quality procedures and to standardise a personalised implant design process. In parallel, I developed and implemented a certified ISO 13485 quality management system for implant design. More recently, I have planned hundreds of robotically-assisted hip and knee replacements, at the cutting edge of orthopaedic surgery.

In my previous role, I led the writing of a successful ARC funding bid on behalf of, and in collaboration with an industrial partner and senior academic investigators. Similarly, I extended my publication record with a range of peer-reviewed contributions on medical design innovation. They addressed mechanical circulatory support specifically, and patient-centred healthcare more generally. This work explored themes of entrepreneurship, design management, usability, quality-of-life, and emotional wellbeing in high-risk scenarios.

At the University of Queensland, I have independently co-ordinated, lectured, and tutored for the brand new Design: Experience (DSGN1200) course, in the new university-wide Bachelor of Design program. I love distilling complex and multi-faceted problems into manageable, testable, and explanatory concepts, especially for students and non-designers.

Associate Professor Alan Pegna is a neuropsychologist whose interests lie in the field of cognitive neuroscience and clinical neuropsychology. After receiving a Masters degree in Psychology from the University of Geneva (Switzerland) and a second Masters degree in Human Physiology from University College London (UK), he obtained his PhD from the University of Geneva, using brain imaging techniques to study spatial processing in both healthy controls and brain-damaged patients.

He worked for over 20 years as a clinical neuropsychologist at Geneva University Hospital, and as an academic at the University of Geneva, where he supervised numerous research projects in the field of visual processing, again in healthy participants and in persons with focal brain lesions.

He joined UQ in 2015, where he now explores the neural basis of visual and spatial processing of emotional stimuli. More specifically, using EEG, he examines the brain's response to different facial expressions, as well as to faces that vary in their perceived approachability (e.g., their apparent trustwothiness). When possible, these studies are also carried out with brain-damaged individuals, in order to investigate the role of particular brain regions in these processes.

.

Dr. Andre A Pekerti is an Associate Professor in International Management within the International Business Discipline, at The University of Queensland Business School. He is an n-Cultural, a Christian of Indonesian-Chinese heritage who grew up in Jakarta, Southern California, and New Zealand, and is a naturalized New Zealander and Australian. Andre’s multicultural background complements his research interest and teaching in international management.

His primary research topics are attributions, acculturation, cultural intelligence, cross-cultural communication, multi-method assessment on n-Culturals and cognitive complexity, ethics, family business, human factors, n-Culturals, servant leadership, social justice, trustworthiness, and wellbeing.

Andre consistently publishes in international journals including, International Journal of Cross-Cultural Management, International Journal of Human Resource Management, Journal of Business Ethics, International Journal of Intercultural Relations, and Journal of International Business Studies.

He served as Vice President of the Australia New Zealand International Business Academy for two terms. He consistently serves as an ad hoc reviewer for several international journals. Currently, he is on the following editorial review boards: Asia-Pacific Journal of Management; Cross-Cultural and Strategic Management; Human Resource Management Review; International Journal of Intercultural Relations; Journal of International Business Studies; Journal of World Business; and Honorary Editor of Andalas Management Review.

Andre initiated the Rapid Acculturation Mateship Program (RAMP) at UQBS. A precursor to Global Mates and BEL Buddies, RAMP is a 19-week program connecting local students with incoming international students. RAMP “Serves to facilitate adjustment to UQ, Australia and the reciprocal learning of cultures”, and has positively affected the experiences of domestic and international students.

Dr. Pekerti has taught in MBA Programs at The University of Auckland, Bond University and UQ Business School. He consulted for Diner’s Club, Singapore; the Department of Transport Victoria, Australia; and the Ministry of Trade, Indonesia. Most recently collaborated with BiasSync, a science-based solution designed to help organizations more effectively assess and manage unconscious bias in the work environment.

Author of n-Culturalism in Managing Work and Life: A new within individual multicultural model.

My research interests have concentrated on the molecular genetic analysis of multigene phenotypes of bacteria encompassing pathogenicity, bacterial degradation of synthetic environmental pollutants, photosynthesis and the synthesis of antitumour antibiotics. My PhD research focussed on plasmids and mapping of the genome of the human pathogen P. aeruginosa (Pemberton,and Holloway, 1972a; Pemberton,and Holloway,1972b;Pemberton and Holloway,1973). I continued this research as a postdoc at UC Berkeley with John Clark in the Department of Molecular Biology in the Wendell Stanley Virus laboratory. I am grateful to Mark Guyer who taught me how to isolate large plasmid DNAs. In Robley Williams lab I learnt how to use the Kleinschmidt and Zahn technique for spreading the plasmid DNA on an electronmicroscope grid and metal shadow the sample to visualise it under an electron microscope; I am grateful to Robley Williams for showing me how to metal shadow my samples (Pemberton,1973; Pemberton and AJ Clark,1973; Miller, Pemberton and Richards,1974;Pemberton,1974;Miller,Pemberton and Clark,1977). After advice from John Clark and when I returned to Australia and took up an appointment with UQ I decided to diversify my research. During my postdoc I worked alongside Anne Emerick who was working with the CAM (camphor degradation) plasmid. John Clark put me on her advisory panel (alongside Mike Doudoroff and Norberto Palleroni) making her my first PhD student. The bacterial degradation of such complex naturally occurring molecules such as camphor required a large number of steps requiring a large number of genes hence a large plasmid. I decided to determine if soil bacteria had evolved plasmids which encoded the degradation of man-made molecules. I chose the synthetic herbicide 2,4-D. My research was the first to identify, isolate and clone genes responsible for the degradation of a man-made molecule –moreover the 2,4-D degradation was encoded by a broad host range plasmid, providing an explanation of how microorganisms rapidly evolve the ability to degrade and recycle a vast array of worldwide synthetic environmental pollutants which cause a range of diseases from cancer to birth defects (Pemberton & Fisher, Nature, 1977). One of the most widely studied microorganisms is the bacterium Ralstonia eutropha JMP134 pJP4 (Hgr) which has an extraordinary ability to degrade and recycle the most complex and most toxic synthetic molecules (Don and Pemberton, J.Bacteriol, 1981;Schmidt et.al.,2011. Catabolic Plasmids.Encyclopedia of Life Sciences). Famously more recent studies have shown that there are genes and gene clusters encoding the degradation of plastics, explosives and chemical weapons of war . Detailed studies of bacterial genes involved in the environmental degradation and recycling of a wide range naturally occurring and synthetic molecules show that degradation genes and degradation gene clusters play a major role in the worldwide carbon cycle.

Photosynthesis is considered the most important biological process on earth. And one of the most intensively studied photosynthetic organisms is the bacterium Rhodobacter sphaeroides. To start the research a local strain of R.sphaeroides, designated RS601, was isolated by Bill Tucker (my first australian PhD student) from a water sample obtained from a roadside ditch in Brisbane (Pemberton and Tucker,1977;Tucker and Pemberton,1978;1979;1980). One of the first discoveries made with this strain was lysogenic conversion to antibiotic resistance by a naturally occurring virus .(JM Pemberton, WT Tucker - Nature, 1977).

Subsequently when this strain was infected withe the broad host plasmid RP1 carrying the mecuric ion transposon Tn501 chromosome transfer occurred. This allowed the construction of the first genetic map of a photosynthetic bacterium(Pemberton and Bowen, J.Bacteriol, 1981). Mapping revealed that the photosynthesis gene cluster was on the main chromosome. Remarkably chromosome transfer occurred from a site right next to the photosynthesis gene cluster with early transfer of the entire cluster into the recipent cell. This provides a potential mechanism for the evolution and spread of photosynthesis genes. A clone bank of RS601 was constructed using pHC79:: Tn5deltaBamH1. This vector allowed cosmid cloning into the BamH1 site of Tn5. These Tn5 cosmid clones were transposed onto the broad host range plasmid pR751. The ability to transfer the entire cosmid clone bank to a wide range of bacteria led to the first cloning and heterologous expression of a carotenoid gene cluster (Pemberton&Harding,Current Microbiology,1986 & 1987).This indicated that genes involved in photosynthesis could be transferred to and expressed in a range of unrelated non-photosynthetic bacteria. Subsequent heterologous expression of carotenoid genes in an increasing variety of plants led to the production of foods enriched in the precursors of vitamin A e.g. Golden Rice (Erik Stokstad, Science Nov 20, 2019) . Vitamin A deficiency is the major preventable cause of blindness in children under 5 years of age; it affects up to 500,000 children each year. Using the same clone bank in mapping experiments in Rhodobacter sphaeroides I observed a few pale colonies in which carotenoid biosynthesis was suppressed. Subsequent detailed analysis of one of these cosmids led to the discovery of the long sought master regulator (PpsR) of bacterial photosynthesis and provided the first detailed insight into the mechanism by which bacterial photosynthesis is regulated at the molecular level (A Gene from the Photosynthetic Gene Cluster of Rhodobacter sphaeroides Induces trans Suppression of Bacteriochlorophyll and Carotenoid Levels in R.sphaeroides and R.capsulatus (R.J.Penfold and JM Pemberton, Current Microbiology, 1991; Sequencing, Chromosomal Inactivation and Functional Expression in E.coli of ppsR a Gene which represses carotenoid and bacteriochlorophyll synthesis in Rhodobacter sphaeroides. RJ Penfold and JM Pemberton. J.Bacteriol May 1994).Early studies by Cohen-Bazire, Sistrom and Stanier (1957) revealed that oxygen and blue light had varying effects on photosynthesis in Rhodobacter. The effect of oxygen was profound. The effect of blue light was more muted. The initial sequencing of ppsR (Penfold and Pemberton, 1994) revealed the presence of only two cys residues suggesting a possible mechanism for the profound effect of oxygen on PpsR repressor activity. Studies of conformational changes/repressor activity of PpsR in the presence and absence of oxygen have produced mixed results(Gomelsky et al.,2000;Masuda and Bauer.,2002). In contrast the muted effect of blue light on photosynthesis appears to be due to the blue light sensitive, anti-repressor AppA. (Gomelsky and Kaplan,1995). It is not known if any other environmental signals modulate PpsR activity.The rhodobacter research led to the construction of pJP5603 which allowed the precise insertion of a defined segment of DNA into a bacterial genome (Penfold and Pemberton,1992 ; Zordan,Beliveau,Trow,Craig and Cormack, 2015). The technique was used to either add functional genes or groups of genes to a precise location in the genome or to precisely target and inactivate individual genes. The site of insertion/mutagenesis is tagged with an antibiotic resistance gene. This process is known as “recombineering” ( Zhang et al., 1988). As with all forms of mutagenesis there are “off target” mutations. The consequences of such ”off target” mutations can range from minimal to extensive.

In a study of a range of genes encoding secreted enzymes involved in the degradation of naturally-occurring biological polymers e.g xylanases, cellulases,amylases, chitinases etc I attempted to obtain secretion genes from Chromobacterium violaceum. Again using the pHC79:: Tn5deltaBamH1 vector used in the study of the photosynthesis genes (Pemberton&Harding,Current Microbiology,1986 & 1987) I constructed a cosmid clone bank of C.violaceum. The clone bank I constructed did not produce secretion genes but instead 2-3 of the clones expressed the intense purple pigmented violacein in E.coli(Pemberton,1986). Subsequent subcloning revealed the gene cluster occupied 8kb and transposon mutagenesis revealed intense blue and intense green intermediates. (Pemberton et.al.,Current Microbiology,1991). I am grateful to Trudy Grossman for the detailed study of this cluster which included sequence analysis and functional characterisation of the violacein biosynthetic pathway (August et al., 2000). The functional analysis of the violacein gene cluster revealed that VioA VioC and VioD belong to the PheA(phenol) /TfdB (2,4-D) group of FAD dependant mono-oxygenases. TfdB is encoded by the 2,4-D degradation gene cluster of the broad host range IncP plasmid pJP4 carried by Ralstonia eutropha JMP134. This provides a link between the degradation of a man-made molecule-2,4-D and the synthesis of an anti-tumour antibiotic-violacein. Remarkably, under certain circumstances this 2,4-D degradation pathway can convert 2,4-D into the well known plant antibiotic-protoanemonin (Blasco,R et al., 1995).In 1983 Burt Ensley , Barry Ratzkin and co-workers (Ensley et al.,Science,1983) discovered that the naphthalene dioxygenase gene from Pseudomonas putida enabled E.coli K12 to synthesise the famous blue dye indigo from tryptophan; a second gene, VioD, from the violacein gene cluster also enabled E.coli K12 to produce indigo (Cheah et al.,Acta Crystallographica,1998). Further studies using the violacein gene cluster led to the development of techniques and vectors that should allow cloning and stable, high level expression of more antibiotic biosynthesis pathways in E.coli K12, particularly pathways from the prolific antibiotic producers the Streptomycetes providing novel antibiotics in the fight against antibiotic resistant pathogens (Sarovich and Pemberton,2007; Philip,Sarovich and Pemberton,2008 & 2009;Ahmetagic & Pemberton, 2010 & 2011;Ahmetagic, Philip ,Sarovich,Kluver and Pemberton,2011).An article published in June 2013 by Stevens and co-workers PLoS ONE 8(5) showed that a native gene cluster from Streptomyces rimosus encoding tetracycline can be directly expressed in E.coli K12.

For the first time researchers have showed the expression of the violacein gene cluster in a eukaryote-the yeast Saccharomyces cerevisiae (Lee et al., 2013). Such a discovery may indicate that the violacein gene cluster can be expressed in organisms which range from microbes to man. It may also indicate that major pathways from microorganisms can be engineered and expressed in a range of eukaryotes. Since violacein is a potent anticancer agent it is of interest to determine if the violacein cluster engineered into bacteria of the microbiome of an animal reduces cancer rates. Alternatively it may be possible to engineer the violacein pathway directly into an animal and observe if cancer rates are reduced. In view of the purported prokaryotic ancestry of eukaryoyic organelles such as mitochondria and chloroplasts ,one possible way of boosting violacein synthesis in eukaryotic cells could be to integrate the violacein gene cluster into organelle DNA.

Finally, violacein is chemically related to the well known anti-cancer drug staurosporine and possesses anticancer, antifungal, anti-parasite, antibacterial and antiviral activities;it might be possible to synthesise structural variants of violacein with more potent activity against various cancers and drug/antibiotic resistant pathogens. Interestingly is now known that violacein producing bacteria associated with the skin microbiome of certain frogs provides some protection against extinction by the worldwide spread of ‘chytrid’ fungus(Harris et.al., 2009). In addition, frogs have been used in cancer studies and may provide a simple model to test the anticancer properties of violacein. Since the violacein gene cluster is expressed in a wide range of bacteria ( Dr D S Philip, personal communication;D.S/Philip.PhD Thesis 2010) and has potent activity against the malarial parasite Plasmodium falciparum and other mosquito borne parasites, there is the possibility that mosquitoes engineered to carry the violacein gene cluster might be resistant to parasite infection. The cluster could be stably incorporated in the genomes of bacteria normally inhabiting the surface or the gut of the mosquito.A recent patent application (United States Patent Application 20170280730) indicates that Chromobacterium introduced into the microbiome of mosquitoes is useful for the prevention of transmission of malaria and dengue virus.In addition, chemical modification of violacein may produce drugs with even higher levels of activity against parasites including the malarial parasite ( Wilkinson et al., 2020). Violacein has activity against the pandemic virus Covid19 and there is some knowledge of its mode of action (Duran et al., 2021). Testing may reveal if it has activity against both Kappa and Delta Covid19 variants.Violacein can inhibit infection by HIV and COVID (Doganci et al., 2022)

• Fellow, American Society for Microbiology
• Fellow, Australian Society for Microbiology

Selected Publications:

• Ahmetagic, Adnan, Philip, Daniel S., Sarovich, Derek S., Kluver, Daniel W. and Pemberton, John M. (2011) Plasmid encoded antibiotics inhibit protozoan predation of Escherichia coli K12. Plasmid, 66 3: 152-158. doi:10.1016/j.plasmid.2011.07.006
• Ahmetagic, Adnan and Pemberton, John M. (2011) Antibiotic resistant mutants of Escherichia coli K12 show increases in heterologous gene expression. Plasmid, 65 1: 51-57. doi:10.1016/j.plasmid.2010.11.004
• Ahmetagic, Adnan and Pemberton, John M. (2010) Stable high level expression of the violacein indolocarbazole anti-tumour gene cluster and the Streptomyces lividans amyA gene in E. coli K12. Plasmid, 63 2: 79-85. doi:10.1016/j.plasmid.2009.11.004
• Philip, Daniel S., Sarovich, Derek S. and Pemberton, John M. (2009) Complete sequence and analysis of the stability functions of pPSX, a vector that allows stable cloning and expression of Streptomycete genes in Escherichia coli K12. Plasmid, 62 1: 39-43. doi:10.1016/j.plasmid.2009.03.002

Emeritus Professor Michael Pender graduated from The University of Queensland in 1974 with First Class Honours in Medicine and a University Medal. Over the next six years he trained as a physician and neurologist at the Royal Prince Alfred Hospital and St Vincent's Hospital, Sydney, and became a Fellow of the Royal Australasian College of Physicians (FRACP) in 1981. During his specialist clinical training he developed a keen interest in multiple sclerosis which he has continued since then. After completing his clinical training in neurology, he was a research scholar in the field of multiple sclerosis at the Institute of Neurology, Queen Square, London, and was awarded a PhD from the University of London and Queen Square Prize for Research in 1983. From 1984 to 1986 he continued this research as a Research Fellow at the John Curtin School of Medical Research, Australian National University, Canberra. In 1987 he was appointed Senior Lecturer in the Department of Medicine, The University of Queensland, at the Royal Brisbane Hospital. In 1989 he was awarded a Doctorate of Medicine from The University of Queensland for his research in the field of multiple sclerosis and was promoted to Reader in Medicine. In 1995 he was promoted to Professor of Medicine (Personal Chair), The University of Queensland, which he held until his retirement in 2021. His main clinical and research interest is multiple sclerosis. He also held the positions of: Consultant Neurologist, Royal Brisbane and Women's Hospital, 1987–2021; Director of Neurology, Royal Brisbane and Women's Hospital, 1992–2005: Director of the Neuroimmunology Research Centre, The University of Queensland, 1991–2007; Director of the Multiple Sclerosis Research Centre, The University of Queensland, 2009–2014; and Clinical Fellow, QIMR Berghofer Medical Research Institute, 2017–2021. In 1996, with the support of the Multiple Sclerosis Society of Queensland, he established a Multiple Sclerosis Clinic at the Royal Brisbane and Women's Hospital. In 2006 he was awarded the Multiple Sclerosis Australia Prize for Multiple Sclerosis Research - "For outstanding commitment and dedication to research into the cause and cure of Multiple Sclerosis in Australia". In 2011 he received the John H Tyrer Prize in Internal Medicine, The University of Queensland, for research in the field of Internal Medicine. He was the Sir Raphael Cilento Orator of the Royal Australasian College of Medical Administrators for 2009 and the W Ian McDonald Lecturer of the Australian and New Zealand Association of Neurologists for 2014. In 2019 he received the John Studdy Award from Multiple Sclerosis Australia for "lifelong commitment and service to research to identify the cause of and potential cure for Multiple Sclerosis". In 2024 he was appointed a Member of the Order of Australia for significant service to medicine, particularly neurology and multiple sclerosis research, and to tertiary education. Major research achievements include: the discovery of apoptosis of autoreactive T cells in the central nervous system as a fundamental mechanism of recovery from autoimmune attack (Journal of the Neurological Sciences 1991, Journal of Autoimmunity 1992, European Journal of Immunology 1994); formulation of a novel hypothesis (The Lancet 1998) proposing a failure of this mechanism in multiple sclerosis; and the further development of this hypothesis into a new paradigm (Trends in Immunology 2003) for the cause of human chronic autoimmune diseases based on infection of autoreactive B cells with the Epstein–Barr virus (EBV), some of the predictions of which have already been verified in multiple sclerosis, rheumatoid arthritis and Sjögren’s syndrome. His EBV hypothesis led to the first clinical trial of EBV-specific T cell therapy in multiple sclerosis (JCI Insight 2018), a trial in which he was a principal investigator.

Group page: https://medicine-program.uq.edu.au/multiple-sclerosis-research-group

Dr Natalie Peng is a lecturer in Accounting at the UQ Business School.

Natalie has taught both financial and management accounting courses at UQ.

Her research interests include superannuation, the production, dissemination and interpretation of information in the financial market, disclosure regulation, and cognitive bias in decision-making and its consequences.

Dr. Xiyue Peng is a Postdoctoral Research Fellow at the Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland. In 2023, she got her PhD from AIBN at UQ under the supervision of A/Prof. Bin Luo and Prof.Lianzhou Wang.

Dr. Xiyue Peng specializes in electrochemical energy storage and conversion systems, focusing primarily on the functional materials and energy storage mechanisms for rechargeable Aluminum and redox flow batteries.

Dr. Huadong Peng is a Senior Research Fellow at the Australian Institute for Bioengineering and Nanotechnology (AIBN), University of Queensland from Jan 2024. He is also a Future Academic Leader with Australia’s Food and Beverage Accelerator (FaBA), and a group leader at UQ's Biosustainability Hub. He earned his PhD from Monash University in 2018, followed by postdoctoral training at Imperial College London and the Technical University of Denmark until 2023. Prior to his PhD, he received his Master Degree from the University of Chinese Academy of Sciences in 2013 and a Bachelor Degree from China Three Gorges University in 2010. Additionally, he worked as a research associate at Novozymes China from November 2013 to January 2015.

Currently, Dr Peng leads the Yeast Engineering and Synthetic Biology (YESBio) research group, focusing on sustainable biomanufacturing through synthetic biology and metabolic engineering. He works closely with Prof. Esteban Marcellin. His expertise includes developing innovative synthetic biology tools (gene assembly, CRISPR genome editing and biosensor), advanced microbial cell factories, and synthetic microbial communities, as well as optimizing metabolic pathways to improve the production of high-value compounds for use in food ingredients, biochemicals, biofuels, and biomedicines.

Dr Peng has secured A$544K in funding, including grants, awards and scholarships. Dr. Peng has published over 30 peer-reviewed papers in prestigious journals like Nature Microbiology, Nature Chemical Biology, PNAS, etc., H-index 15 (google scholar Sep 2024). He is a recipient of the prestigious Marie Skłodowska-Curie Fellowship, Chinese Government Award for Outstanding Self-financed Students Abroad and has delivered invited presentations at major international conferences.

Dr. Peng is also an Associate Investigator at the ARC Centre of Excellence in Synthetic Biology (CoESB) and actively contributes to the scientific community through editorial roles such as The Innovation, BioDesign Research and mLife.

Dr Peng is looking for highly motivated Honours, Master and Ph.D. students, and highly competitive full scholarship may be provided. The University of Queensland ranks in the top 50 as measured by the Performance Ranking of Scientific Papers for World Universities. The University also ranks 45 in the QS World University Rankings, 52 in the US News Best Global Universities Rankings, 60 in the Times Higher Education World University Rankings and 55 in the Academic Ranking of World Universities.

Yang is currently a Honorary Research Fellow in UQ School of Public Health and a Research Fellow in Cancer Epidemiology Division of Cancer Council Victoria. He has extensive experience in analysing large-scale national and international health surveys and hospitalisaiton datasets with complex statistical models. He is interested in answering a couple of research questions in the population level (e.g. the associations between modifiable behaviors and chronic diseases; the inequalities in chronic disease risk).

Biography:

Dr. Hong (Marco) Peng is now an Amplify Senior Lecturer at School of Chemical Engineering, the University of Queensland (UQ). He gained his PhD degree in Chemical Engineering at UQ with OZ Minerals Award for Excellent Thesis (2014). He had also the industry experience as a chemical engineer at Olympic Dam site and Newcastle Technology centre, BHP Billiton (2006-2009).

Research:

His research focuses on fundamental aspects of chemical engineering processes, with a specialization in unlocking nucleation and crystallization phenomena with projects on utilization of waste resource as functional materials for critical metals and carbon capture & utilization. Dr. Peng is CI for ARC Research Hub for PVRS and ARC Training Centre for the Global Hydrogen Economy and the recipient of the prestigious Advance Queensland Industry Research Fellowships (Both Early and Middle Career).

Projects and Research Grants:

1. Desilication Product Seed for Sandy DSP Process, Rio Tinto,2023 (Leading CI)
2. Lime reduction during pressure oxidation of gold-bearing sulphides, Newcrest, 2023 (Leading CI)
3. Controlling iron precipitation during pressure oxidation of gold-bearing sulphides, Newcrest, 2022-2023 (Leading CI)
4. Metal-based zeolite catalyst development for CO2 hydrogenation, 2022-2025, ARC Training Centre for the Global Hydrogen Economy (Co-CI)
5. The effect of anions on early stage co-growth of desilication products (DSP) in a synthetic Bayer solution, 2022, Australian Synchrotron Access Program (ANSTO) (Leading CI)
6. Developing low cost technology to turn clay to zeolite. Advance Queensland Industry Research Fellowship (Middle Career), 2020-2023, Queensland Government (Sole CI)
7. Green synthesis of adsorption materials from clay minerals, 2019-2020, UniQuest pathfinder (Leading CI)
8. Unlocking Queensland's bauxite ore reserves through process technology innovation. Advance Queensland Research Fellowship (Early Career), 2016-2019, Queensland Government (Sole-CI)

Teaching and Learning:

• Lecturer and Coordinator in Chemical Thermodynamics (CHEE3003), since 2021
• Lecturer in Engineering Investigation & Statistical Analysis (CHEE2010), since 2019
• ENGG7290 Engineering Placement, BE/ME course, Academic supervisor and Grader, since 2018
• Lecturer in Process Modelling and Dynamics (CHEE3007), 2018-2019

Honours And Awards

1. TMS Young Leaders Professional Development Awards,2020
2. UQ Amplify Fellowship (early career and mid-career), 2019-2021, 2023-2026
3. Travel award for Universitas 21 Early Career Researcher Workshop, 2018
4. Best Alumina Paper in ICSOBA Conference, 2017
5. OZ Minerals Award for Excellent PhD thesis, 2014

Academic and Discipline service

1. Vice Chair of Recycling and Environmental Technologies Committee, The Minerals, Metals & Materials Society (TMS), 2022-
2. Academic Representative of Joint Chemical Engineering Committee – Queensland (IChemE and Engineering Australia), 2020-
3. Secretary of Hydrometallurgy and Electrometallurgy Committee, The Minerals, Metals & Materials Society (TMS), 2021-2023
4. Leading topic editor for JOM, “Reprocessing and Recycling of Tailings from Metallurgical Process”,2022; “Progress on Recovery of Critical Raw Materials, 2021”; “Advances in Process Metallurgy,2020”

Research Interests

• Mineral Processing and Extractive Metallurgy

Precipitation, crystallisation, bioleaching, froth flotation, nanobubbles

• Chemical Engineering

Valorisation of bauxite residue and mine tailings, Zeolite, Alum, Environmental functional materials, MD Simulation